With the increase of patients experiencing heart failure and clinical challenges to manage advanced heart failure conditions, therapies with implantable devices have become an essential treatment method.
The current standard of care for heart failure (HF) is guideline-directed medical therapy combined with device-based interventions in eligible patients.

FineHeart granted first two FLOWMAKER® patents in China